Abstract
To do a bibliographic review of the given association of atopic [AD] and immunological diseases with central nerve system tumors [CNST] described a few years ago and to know the knowledge available. It gives an overview of the studies describing this association, and those explaining its mechanism. A negative association of AD with CNST stands out in case-control studies, which is not observed in cohort studies. The greatest association is seen for gliomas and is less significant for meningiomas. A clearer definition for the AD under study, tumour types, and the exact biochemical and clinical parameters to help diagnoses are the recommended as well as to establish an aetiologic and temporal relationship between AD and CNST.
Keywords: Allergy, atopy, asthma, brain tumour, brain tumour risk, epidemiology brain tumour, glioma, immunology, meningioma, central nerve system tumors
Inflammation & Allergy - Drug Targets (Discontinued)
Title: Immunologic Diseases and Brain Tumors
Volume: 10 Issue: 3
Author(s): Maria Morales-Suarez-Varela, Marina Pollan, Nuria Aragones, Teresa Garcia-Martinez, Raquel Solis-Plaza and Agustin Llopis-Gonzalez
Affiliation:
Keywords: Allergy, atopy, asthma, brain tumour, brain tumour risk, epidemiology brain tumour, glioma, immunology, meningioma, central nerve system tumors
Abstract: To do a bibliographic review of the given association of atopic [AD] and immunological diseases with central nerve system tumors [CNST] described a few years ago and to know the knowledge available. It gives an overview of the studies describing this association, and those explaining its mechanism. A negative association of AD with CNST stands out in case-control studies, which is not observed in cohort studies. The greatest association is seen for gliomas and is less significant for meningiomas. A clearer definition for the AD under study, tumour types, and the exact biochemical and clinical parameters to help diagnoses are the recommended as well as to establish an aetiologic and temporal relationship between AD and CNST.
Export Options
About this article
Cite this article as:
Morales-Suarez-Varela Maria, Pollan Marina, Aragones Nuria, Garcia-Martinez Teresa, Solis-Plaza Raquel and Llopis-Gonzalez Agustin, Immunologic Diseases and Brain Tumors, Inflammation & Allergy - Drug Targets (Discontinued) 2011; 10 (3) . https://dx.doi.org/10.2174/187152811795564082
DOI https://dx.doi.org/10.2174/187152811795564082 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Articles
-
Endoplasmic Reticulum Stress and Bipolar Disorder - Almost Forgotten Therapeutic Drug Targets in the Unfolded Protein Response Pathway Revisited
CNS & Neurological Disorders - Drug Targets Development of <sup>18</sup>F-Labeled PET Probes for Imaging Cell Proliferation
Current Topics in Medicinal Chemistry Molecular Mechanisms Regulating the Mitochondrial Targeting of Microsomal Cytochrome P450 EnzymesMolecular Mechanisms Regulating the Mitochondrial Targeting of Microsomal Cytochrome P450 Enzymes
Current Drug Metabolism Current Developments in Targeted Drug Delivery Systems for Glioma
Current Pharmaceutical Design Editorial (Thematic Selection: Mitochondrial Dysfunction & Neurological Disorders)
Current Neuropharmacology <sup>177</sup>Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay
Current Radiopharmaceuticals Curcumin in Combined Cancer Therapy
Current Pharmaceutical Design Exploring the Role of Phytochemicals as Potent Natural Photosensitizers in Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Recent Approaches for Studying the Role of Glia
CNS & Neurological Disorders - Drug Targets Transductional Targeting with Recombinant Adenovirus Vectors
Current Gene Therapy Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design Protective Role of Natural Products in Glioblastoma Multiforme: A Focus on Nitric Oxide Pathway
Current Medicinal Chemistry [11C]Meta-Hydroxyephedrine PET/CT
Current Radiopharmaceuticals Perspectives in Engineered Mesenchymal Stem/Stromal Cells Based Anti- Cancer Drug Delivery Systems
Recent Patents on Anti-Cancer Drug Discovery Factors Interacting with HIF-1α mRNA: Novel Therapeutic Targets
Current Pharmaceutical Design New Platinum and Ruthenium Complexes - the Latest Class of Potential Chemotherapeutic Drugs - a Review of Recent Developments in the Field
Mini-Reviews in Medicinal Chemistry Cognitive, Psychological and Psychiatric Effects of Ionizing Radiation Exposure
Current Medicinal Chemistry ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis
Current Pharmaceutical Design Brain Cancer-Activated Microglia: A Potential Role for Sphingolipids
Current Medicinal Chemistry The Pathophysiological Role of PEDF in Bone Diseases
Current Molecular Medicine